SARS-CoV-2-associated Takotsubo is not necessarily triggered by the infection

SARS-CoV-2-associated Takotsubo is not necessarily triggered by the infection

Bibliographic Details
Main Author:	Josef Finsterer
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Series:	International Journal of Cardiology: Heart & Vasculature
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352906720303043

Similar Items

Reply to “SARS-CoV-2-associated Takotsubo is not necessarily triggered by the infection”
by: Yasar Sattar, et al.
Published: (2020-10-01)

Pathophysiology of SARS-CoV-2-associated ischemic stroke is variegated
by: Fulvio A. Scorza, et al.
Published: (2021-09-01)

SARS-CoV-2-associated critical ill myopathy or pure toxic myopathy?
by: Josef Finsterer, et al.
Published: (2020-12-01)

Does SARS-CoV-2 truly cause infectious myopathy?
by: Josef Finsterer, et al.
Published: (2021-03-01)

Thrombus of the Aorta and SARS-CoV-2 Infection: Cause or Trigger?
by: Guillaume Goudot, et al.
Published: (2021-09-01)

SARS‐CoV‐2 infection as a trigger of autoimmune response
by: Maria C. Sacchi, et al.
Published: (2021-05-01)

Fatal SARS-CoV-2 Associated Rhabdomyolysis Requires Elucidation
by: Josef Finsterer, et al.
Published: (2021-03-01)

Is SARS-CoV-2 responsible for relapses of Parkinson’s disease?
by: Fulvio A. Scorza, et al.
Published: (2021-07-01)

Central Nervous System (CNS) Disease Triggering Takotsubo Syndrome
by: Josef Finsterer, et al.
Published: (2016-01-01)

Diabetes and coronavirus infections (SARS-CoV, MERS-CoV, and SARS-CoV-2)
by: Azadeh Haghi Navand, et al.
Published: (2020-01-01)

Guillain-Barre syndrome 15 days after COVID-19 despite SARS-CoV-2 vaccination
by: Josef Finsterer
Published: (2021-01-01)

SARS-CoV-2 as Well as Anti-COVID-19 Treatment May Cause Rhabdomyolysis
by: Josef Finsterer MD, PhD
Published: (2021-02-01)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
by: Yun-yu Zhang, et al.
Published: (2020-08-01)

SARS-CoV-2 and Glutamine: SARS-CoV-2 Triggered Pathogenesis via Metabolic Reprograming of Glutamine in Host Cells
by: Shiv Bharadwaj, et al.
Published: (2021-01-01)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
by: Yong Xia, et al.
Published: (2020-07-01)

Organizing pneumonia associated with SARS-CoV-2 infection
by: Julián Mauricio Cortés Colorado, Neumology and critical medicine specialist. Professor of Neumology., et al.
Published: (2021-09-01)

Myopathy associated with severe SARS-CoV-2 infection
by: M.J. Abenza Abildúa, et al.
Published: (2020-11-01)

Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection
by: Nazzarena Labò, et al.
Published: (2020-06-01)

Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
by: Huibin Lv, et al.
Published: (2020-06-01)

Comparison between SARS-CoV and SARS-CoV 2
by: Fang Meng
Published: (2021-01-01)

Neuropathogenesis of SARS-CoV-2 infection
by: Shumayila Khan, et al.
Published: (2020-07-01)

SARS-CoV-2 Infection and the Newborn
by: Fahri Ovalı
Published: (2020-05-01)

SARS-CoV-2 Infection and the Liver
by: Katie Morgan, et al.
Published: (2020-05-01)

Neonatal SARS-CoV-2 infection
by: Werther Brunow de Carvalho, et al.

Intussusception and SARS-CoV-2 infection
by: Israel Mercado-Martínez, et al.
Published: (2021-04-01)

SARS-CoV-2-Host Chimeric RNA-Sequencing Reads Do Not Necessarily Arise From Virus Integration Into the Host DNA
by: Anastasiya Kazachenka, et al.
Published: (2021-06-01)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01)

H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection
by: Nan Zhou, et al.
Published: (2021-01-01)

H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection
by: Bao, J., et al.
Published: (2021)

Attributing increased prevalence of facial palsy to SARS‐CoV‐2 requires evidence
by: Josef Finsterer, et al.
Published: (2021-02-01)

Dataset of mutational analysis, miRNAs targeting SARS-CoV-2 genes and host gene expression in SARS-CoV and SARS-CoV-2 infections
by: Rahila Sardar, et al.
Published: (2020-10-01)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
by: Qingqing Lin, et al.
Published: (2020-10-01)

Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections
by: Ren Yang, et al.
Published: (2020-08-01)

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
by: Yanwen Liang, et al.
Published: (2020-05-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

Parsonage-Turner syndrome association with SARS-CoV-2 infection
by: Cristóbal Díaz, MD, et al.
Published: (2021-08-01)

Exuberant bullous vasculitis associated with SARS-CoV-2 infection
by: Pedro Alves da Cruz Gouveia, et al.
Published: (2021-01-01)

Guillain-Barré Syndrome associated with SARS-CoV-2 infection
by: Ahmed Virani, et al.
Published: (2020-01-01)

Guillain-Barré syndrome associated with SARS-CoV-2 infection
by: A. Velayos Galán, et al.
Published: (2020-05-01)

SARS-CoV-2 Infection with Associated Rhabdomyolysis and Probable Myocarditis
by: Franco Murillo, et al.
Published: (2020-08-01)